TGF-β1 was considerably down-regulated in the CKD + ECF group (20.8 mg/d); Smad3 and phospho-Smad3 were significantly down-regulated in the CKD + EC group (15.6 mg/d). Here, SMAD3 is linked to chronic kidney disease.